Anavex Life Sciences Announces Publication of Clinical Data for ANAVEX®2-73 (blarcamesine) in Alzheimer’s Disease

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing